Concepedia
Statistics
Publications
37
Citations
3.3K
H-Index
25
Active since
2000
Affiliations
Chugai Pharma (United States)(Current)
The University of Tokyo
Nara Medical University
Mochida Pharmaceutical (Japan)
Tomoyuki Igawa is an author at Chugai Pharma (United States) specializing in immunology, antibody engineering, and pharmacy.
Publications per year
2000–2024
A bispecific antibody to factors IXa and X restores factor VIII hemostatic activity in a hemophilia A model
Takehisa Kitazawa, Tomoyuki Igawa, Zenjiro Sampei et al. · Nature Medicine · 2012 · 496 citations
Medicine, Hematology, Immunology +17
Antibody recycling by engineered pH-dependent antigen binding improves the duration of antigen neutralization
Tomoyuki Igawa, Shinya Ishii, Tatsuhiko Tachibana et al. · Nature Biotechnology · 2010 · 351 citations
Pharmacy, Biotechnology, Immunology +13
Identification and Multidimensional Optimization of an Asymmetric Bispecific IgG Antibody Mimicking the Function of Factor VIII Cofactor Activity
Zenjiro Sampei, Tomoyuki Igawa, Tetsuhiro Soeda et al. · PLoS ONE · 2013 · 325 citations · Full text
Pharmacy, Biotechnology, Medicinal Chemistry +17
Reduced elimination of IgG antibodies by engineering the variable region
Tomoyuki Igawa, Hiroyuki Tsunoda, Tatsuhiko Tachibana et al. · Protein Engineering Design and Selection · 2010 · 262 citations
Pharmacy, Immunology, Pharmacokinetics +17
An anti–glypican 3/CD3 bispecific T cell–redirecting antibody for treatment of solid tumors
Takahiro Ishiguro, Yuji Sano, Shunichiro Komatsu et al. · Science Translational Medicine · 2017 · 203 citations
Medicine, Oncology, Pharmacology +15
1–5 of 37